Hcy

Homocysteine

Metabolic Panel

What is Homocysteine?

Homocysteine is a sulfur-containing amino acid produced as an intermediate in the metabolism of methionine, an essential amino acid obtained from dietary protein. Homocysteine sits at a critical metabolic crossroads: it can be recycled back to methionine through a reaction requiring vitamin B12 and folate (via methionine synthase), or it can be irreversibly converted to cysteine through the transsulfuration pathway requiring vitamin B6 (via cystathionine beta-synthase). When either of these pathways is impaired—due to vitamin deficiencies, genetic enzyme variants, or kidney dysfunction—homocysteine accumulates in the blood.

Elevated homocysteine (hyperhomocysteinemia) has been extensively studied as a risk factor for cardiovascular disease, venous thromboembolism, and cognitive decline. While the relationship between homocysteine and vascular disease is well-established observationally, clinical trials of B-vitamin supplementation to lower homocysteine have shown inconsistent results in reducing cardiovascular events—creating one of the most debated topics in preventive cardiology. Nevertheless, homocysteine measurement remains valuable for diagnosing B-vitamin deficiencies, evaluating unexplained thrombosis, and screening for rare inborn errors of metabolism.

Why It Matters

Elevated homocysteine is a marker of impaired folate, B12, or B6 metabolism and is an independent risk factor for atherosclerotic cardiovascular disease, stroke, venous thromboembolism, and dementia. In younger patients with unexplained blood clots or premature cardiovascular disease, high homocysteine can identify treatable vitamin deficiencies or genetic conditions. Severe hyperhomocysteinemia from homocystinuria (a genetic condition) causes intellectual disability, skeletal abnormalities, lens dislocation, and early vascular events if untreated. Homocysteine is also one of the most sensitive functional markers of folate and B12 sufficiency.

Normal Reference Ranges

GroupRangeUnit
Adults5–15µmol/L
Mild elevation15–30µmol/L
Moderate elevation30–100µmol/L
Severe elevation>100µmol/L

Reference ranges may vary by laboratory. Always compare results to the ranges provided by your testing facility.

What High Hcy Levels Mean

Common Causes

  • Folate (vitamin B9) deficiency
  • Vitamin B12 deficiency
  • Vitamin B6 deficiency
  • MTHFR gene polymorphisms (C677T, A1298C)
  • Chronic kidney disease (impaired clearance)
  • Hypothyroidism
  • Homocystinuria (rare genetic condition)
  • Medications (methotrexate, phenytoin, carbamazepine, nitrous oxide)
  • Smoking and excessive coffee intake

Possible Symptoms

  • Often asymptomatic
  • Premature cardiovascular disease or stroke
  • Unexplained deep vein thrombosis or pulmonary embolism
  • Cognitive decline and memory problems
  • Fatigue (if due to B-vitamin deficiency)
  • In homocystinuria: lens dislocation, tall stature, skeletal abnormalities, intellectual disability

What to do: Check folate, vitamin B12, vitamin B6, and renal function. The most common cause of elevated homocysteine is B-vitamin deficiency, which is easily treatable. Supplementation with folic acid (400–1000 µg/day), vitamin B12, and B6 typically normalizes homocysteine within 6–8 weeks. If levels remain elevated despite supplementation, consider MTHFR genotyping, kidney disease, hypothyroidism, or medication effects. Very high levels (>50 µmol/L) in young patients should prompt evaluation for homocystinuria with plasma amino acids and genetic testing. Address modifiable risk factors including smoking cessation.

What Low Hcy Levels Mean

Common Causes

  • Low homocysteine is generally not clinically significant
  • May be seen with high-dose B-vitamin supplementation
  • Hyperthyroidism

Possible Symptoms

  • Low homocysteine does not cause symptoms

What to do: Low homocysteine is not a clinical concern and generally does not require any action. It may simply reflect excellent B-vitamin status or efficient homocysteine metabolism.

When Is Hcy Testing Recommended?

  • When evaluating unexplained thrombotic events, especially in young patients
  • When premature cardiovascular disease is present without traditional risk factors
  • When vitamin B12 or folate deficiency is suspected
  • As part of thrombophilia workup
  • When screening family members of patients with homocystinuria
  • When evaluating unexplained cognitive decline

Frequently Asked Questions

This remains one of the most debated questions in cardiology. Observational studies consistently show that elevated homocysteine is associated with a 20–30% increased risk of cardiovascular events. However, large randomized controlled trials (HOPE-2, VISP, NORVIT) that used B-vitamin supplementation to lower homocysteine found either no benefit or mixed results in preventing heart attacks and strokes. Possible explanations include: homocysteine may be a marker rather than a cause of vascular disease, the damage from chronic elevation may be irreversible by the time treatment starts, or the trials may not have been long enough. Current guidelines do not recommend screening or treating elevated homocysteine solely for cardiovascular prevention in the general population, but testing remains valuable for diagnosing B-vitamin deficiency and evaluating unexplained thrombosis.
MTHFR (methylenetetrahydrofolate reductase) is an enzyme critical for folate metabolism and homocysteine recycling. The C677T variant, present in 10–15% of North Americans in homozygous form, reduces enzyme activity by about 70% and can elevate homocysteine, particularly when folate intake is low. The A1298C variant has milder effects. However, routine MTHFR genetic testing is NOT recommended by major medical societies because: (1) having the variant does not reliably predict elevated homocysteine or clinical events, (2) treatment is the same regardless of MTHFR status—ensure adequate folate intake, and (3) folate fortification of grains has reduced the clinical impact. Simply checking homocysteine itself is more clinically useful than genotyping MTHFR.
The kidneys play a major role in homocysteine metabolism, both through renal clearance and through metabolic conversion in kidney tubular cells. As kidney function declines, homocysteine levels rise progressively—moderately elevated homocysteine (15–30 µmol/L) is found in most patients with CKD stages 3–5, and levels can exceed 50 µmol/L in dialysis patients. Interestingly, while homocysteine is elevated in virtually all dialysis patients, B-vitamin supplementation lowers levels but has not convincingly reduced cardiovascular events in this population. This further supports the hypothesis that in CKD, homocysteine may be a marker of uremic burden rather than a direct cause of vascular damage.

Related Biomarkers

B12Vitamin B12FolateFolateCrCreatinineeGFREstimated Glomerular Filtration Rate

Want your Hcy levels analyzed?

Upload your lab results for an instant AI-powered breakdown of all your biomarkers.

Upload Lab Results →

Medical Disclaimer: This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Reference ranges may vary between laboratories. Always consult your healthcare provider for interpretation of your specific test results.

Disclaimer: SymptomGPT is not a medical diagnosis tool and does not provide medical advice. Always consult a qualified healthcare professional. If you are experiencing a medical emergency, call 911 immediately.